SPECC1L and non-small cell lung carcinoma: This is the first report on SPECC1L::ALK rearrangement in an NSCLC patient with a breakpoint in exon 7 of SPECC1L, which was identified using AMP-NGS technology and then investigated at the protein level by an in silico prediction model to clarify the pathogenicity of this rare event.